UK Expert Panel

How do the clinical definitions of TTS, VITT and anti‑PF4‑positive cases differ and how does that affect incidence estimates?

VITT is a specific, pathogenic subset of the broader surveillance label TTS defined by clinical timing and laboratory proof of platelet‑activating anti‑PF4 antibodies, while “anti‑PF4‑positive” cases ...